Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine

Abstract Background Tardive dyskinesia (TD) is a movement disorder related to long‐term antipsychotic use and characterized by involuntary repetitive movements that often affect the oral and facial muscles. Although valbenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor, is an effective...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuhei Mori, Yuhei Suzuki, Akiko Sato, Risa Shishido, Yuri Kobayashi, Yuta Fukuchi, Shota Inada, Yuka Iwasaki, Riko Sato, Keitaro Takada, Naoki Morita, Itaru Miura
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:PCN Reports
Subjects:
Online Access:https://doi.org/10.1002/pcn5.70135
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849430554291732480
author Yuhei Mori
Yuhei Suzuki
Akiko Sato
Risa Shishido
Yuri Kobayashi
Yuta Fukuchi
Shota Inada
Yuka Iwasaki
Riko Sato
Keitaro Takada
Naoki Morita
Itaru Miura
author_facet Yuhei Mori
Yuhei Suzuki
Akiko Sato
Risa Shishido
Yuri Kobayashi
Yuta Fukuchi
Shota Inada
Yuka Iwasaki
Riko Sato
Keitaro Takada
Naoki Morita
Itaru Miura
author_sort Yuhei Mori
collection DOAJ
description Abstract Background Tardive dyskinesia (TD) is a movement disorder related to long‐term antipsychotic use and characterized by involuntary repetitive movements that often affect the oral and facial muscles. Although valbenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor, is an effective treatment of TD, it may induce drug‐induced parkinsonism (DIP) in some patients. Electroconvulsive therapy (ECT) improves depressive symptoms and certain movement disorders; however, its role in managing TD, particularly in patients intolerant to VMAT2 inhibitors because of DIP, remains elusive. Case Presentation Herein, we describe a 65‐year‐old Japanese woman with a history of major depressive episodes and oral dyskinesia. The patient was treated with valbenazine for oral dyskinesia; however, she developed DIP, requiring valbenazine discontinuation. After the worsening of depression, the patient was hospitalized and underwent 10 sessions of modified ECT, which remarkably helped improving depressive symptoms and oral dyskinesia. Conclusion This case suggests that ECT could be a viable treatment option for managing patients with depression and oral dyskinesia who are susceptible of valbenazine‐induced parkinsonism.
format Article
id doaj-art-4a1caafcebb84bd0a0cbe86f1b780cfb
institution Kabale University
issn 2769-2558
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series PCN Reports
spelling doaj-art-4a1caafcebb84bd0a0cbe86f1b780cfb2025-08-20T03:27:57ZengWileyPCN Reports2769-25582025-06-0142n/an/a10.1002/pcn5.70135Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazineYuhei Mori0Yuhei Suzuki1Akiko Sato2Risa Shishido3Yuri Kobayashi4Yuta Fukuchi5Shota Inada6Yuka Iwasaki7Riko Sato8Keitaro Takada9Naoki Morita10Itaru Miura11Department of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanDepartment of Neuropsychiatry, School of Medicine Fukushima Medical University Fukushima JapanAbstract Background Tardive dyskinesia (TD) is a movement disorder related to long‐term antipsychotic use and characterized by involuntary repetitive movements that often affect the oral and facial muscles. Although valbenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor, is an effective treatment of TD, it may induce drug‐induced parkinsonism (DIP) in some patients. Electroconvulsive therapy (ECT) improves depressive symptoms and certain movement disorders; however, its role in managing TD, particularly in patients intolerant to VMAT2 inhibitors because of DIP, remains elusive. Case Presentation Herein, we describe a 65‐year‐old Japanese woman with a history of major depressive episodes and oral dyskinesia. The patient was treated with valbenazine for oral dyskinesia; however, she developed DIP, requiring valbenazine discontinuation. After the worsening of depression, the patient was hospitalized and underwent 10 sessions of modified ECT, which remarkably helped improving depressive symptoms and oral dyskinesia. Conclusion This case suggests that ECT could be a viable treatment option for managing patients with depression and oral dyskinesia who are susceptible of valbenazine‐induced parkinsonism.https://doi.org/10.1002/pcn5.70135depressiondyskinesiaelectroconvulsive therapyparkinsonismvalbenazine
spellingShingle Yuhei Mori
Yuhei Suzuki
Akiko Sato
Risa Shishido
Yuri Kobayashi
Yuta Fukuchi
Shota Inada
Yuka Iwasaki
Riko Sato
Keitaro Takada
Naoki Morita
Itaru Miura
Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
PCN Reports
depression
dyskinesia
electroconvulsive therapy
parkinsonism
valbenazine
title Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
title_full Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
title_fullStr Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
title_full_unstemmed Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
title_short Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
title_sort electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
topic depression
dyskinesia
electroconvulsive therapy
parkinsonism
valbenazine
url https://doi.org/10.1002/pcn5.70135
work_keys_str_mv AT yuheimori electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT yuheisuzuki electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT akikosato electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT risashishido electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT yurikobayashi electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT yutafukuchi electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT shotainada electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT yukaiwasaki electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT rikosato electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT keitarotakada electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT naokimorita electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine
AT itarumiura electroconvulsivetherapyfordepressionandoraldyskinesiainapatientwhodevelopedparkinsonisminducedbyvalbenazine